This paper discusses the administrative aspects of molecular diagnostics in oncology, including US Food and Drug Administration (FDA) oversight, the regulatory approval process, clinical, and ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics ...

Molecular diagnostic (MDx) tests should provide results quickly and reliably. By choosing instruments, reagents, software, services, and support offerings that exist in a single MDx ecosystem, ...

The use of molecular diagnostics with real-time PCR-based tests can greatly expedite the testing process and deliver results within hours for rapid medical intervention.

CRISPR and next-generation sequencing are transforming molecular diagnostics, from infectious disease to early cancer detection. Where might the science lead?

UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular platform at Medica 2022 in Dusseldorf (14-17 November).

Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types.

Anavasi Diagnostics Receives FDA Emergency Use Authorization for The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector New Reusable Molecular Detector Reduces Biowaste in Clinical Use ...